派林生物(000403.SZ)：上半年净利润2.36亿元 同比下降27.89%

Core Viewpoint - The company reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 986 million yuan, a year-on-year decrease of 13.18% [1] - The net profit attributable to shareholders was 236 million yuan, down 27.89% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 215 million yuan, reflecting a year-on-year decline of 27.63% [1] - The basic earnings per share were 0.25 yuan [1]